Complex ANDAs: Early Meetings With FDA Can Generate Bonus Communication

 
• By Derrick Gingery
  
FDAEntrance_1200x675
FDA outlines formal meeting process for sponsors of complex generic drugs.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Generics

More from Biosimilars & Generics